CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA

Journal of Clinical Virology

Volumn 46, Issue 3, 2009, Pages 259-264

  Sendi, Hossein ^a,b,c,d   Mehrab Mohseni, Marjan ^a,d   Shahraz, Saeid ^e   Norder, Helene ^a,b   Alavian, Seyed Moayed ^f   Noorinayer, Babak ^g   Zali, Mohammad R ^g   Pumpens, Paul ^h   Bonkovsky, Herbert L ^c,d   Magnius, Lars O ^a,b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^d CAROLINAS MEDICAL CENTER   (United States)

^e Harvard Initiative for Global Health   (United States)

^f Baqiyatallah Research Center for Gastroenterology and Liver Disease   (Iran)

^g SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

Author keywords

HBcAg; Hepatitis B; Immune; Iran; Tc; Viral load

Indexed keywords

EPITOPE; HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IRAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; VIRUS LOAD;

AMINO ACID SEQUENCE; CARRIER STATE; CHI-SQUARE DISTRIBUTION; DNA, VIRAL; EPITOPES; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; LOGISTIC MODELS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIVARIATE ANALYSIS; MUTATION; SEQUENCE ALIGNMENT; T-LYMPHOCYTES, CYTOTOXIC;

EID: 72049105337     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.08.002     Document Type: Article

References (25)

1. Hadziyannis S.J. Hepatitis Be antigen negative chronic hepatitis B. From clinical recognition to pathogenesis and treatment. Vir Hep Rev 1 (1995) 7-36
2. Hur G.M., Lee Y.I., Suh D.J., Lee J.H., and Lee Y.I. Gradual accumulation of mutations in precore core region of HBV in patients with chronic active hepatitis: implication of clustering changes in a small region of the HBV core region. J Med Virol 48 (1996) 38-46
3. Wynne S.A., Crowther R.A., and Leslie A.G. The crystal structure of the human hepatitis B virus capsid. Mol Cell 3 (1999) 771-780
4. Salfeld J., Pfaff E., Noah M., and Schaller H. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol 63 (1989) 798-808
5. Sallberg M., Ruden U., Magnius L.O., Harthus H.P., Noah M., and Wahren B. Characterisation of a linear binding site for a monoclonal antibody to hepatitis B core antigen. J Med Virol 33 (1991) 248-252
6. Sallberg M., Pushko P., Berzinsh I., Bichko V., Sillekens P., Noah M., et al. Immunochemical structure of the carboxy-terminal part of hepatitis B e antigen: identification of internal and surface-exposed sequences. J Gen Virol 74 (1993) 1335-1340
7. Colucci G., Beazer Y., Cantaluppi C., and Tackney C. Identification of a major hepatitis B core antigen (HBcAg) determinant by using synthetic peptides and monoclonal antibodies. J Immunol 141 (1998) 4376-4380
8. Bertoletti A., Ferrari C., Fiaccadori F., Penna A., Margolskee R., Schlicht H.J., et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci USA 88 (1991) 10445-10449
9. Ferrari C., Bertoletti A., Penna A., Cavalli A., Valli A., Missale G., et al. Identification of immunodominant T cell epitopes of the hepatitis B virus necleocapsid antigen. J Clin Invest 88 (1991) 214-222
10. Wakita T., Kakumu S., Tsutsumi Y., Yoshioka K., Machida A., Mayumi M., et al. Gamma-interferon production in response to hepatitis B core protein and its synthetic peptides in patients with chronic hepatitis B virus infection. Digestion 47 (1990) 149-155
11. Chisari F.V., and Ferrari C. Hepatitis B virus immunopathogenesis. Ann Rev Immunol 13 (1995) 29-60
12. Bertoletti A., Chisari F.V., Penna A., Guilhot S., Galati L., Missale G., et al. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol 67 (1993) 2376-2380
13. Bertoletti A., and Gehring A.J. The immune response during hepatitis B virus infection. J Gen Virol 87 (2006) 1439-1449
14. Missale G., Redeker A., Person J., Fowler P., Guilhot S., Schlicht H.J., et al. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med 177 (1993) 751-762
15. Penna A., Chisari F.V., Bertoletti A., Missale G., Fowler P., Giuberti T., et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 174 (1991) 1565-1570
16. Nayersina R., Fowler P., Guilhot S., Missale G., Cerny A., Schlicht H.J., et al. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 150 (1993) 4659-4671
17. Sendi H., Mehrab-Mohseni M., Zali M.R., Norder H., and Magnius L.O. T1764G1766 core promoter double mutants are restricted to Hepatitis B virus strains with an A1757 and are common in genotype D. J Gen Virol 86 (2005) 2451-2458
18. Arauz-Ruiz P., Norder H., Visona K.A., and Magnius L.O. Genotype F prevails in HBV infected patients of hispanic origin in Central America and may carry the preC stop mutant. J Med Virol 51 (1997) 305-312
19. Bates P.A., Kelley L.A., MacCallum R.M., and Sternberg M.J.E. Enhancement of protein modelling by human intervention in applying the automatic programs 3D-JIGSAW and 3D-PSSM. Proteins: Structure, Function and Genetics Suppl. 5 (2001) 39-46
20. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25 (2004) 1605-1612
21. Valenzuela P., Quiroga M., Zaldivar J., Gray P., and Rutter W.J. The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes. In: Fields B.N., Jaenisch R., and Fox C.F. (Eds). Animal Virus Genetics (1980), Academic Press, New York 57-70
22. Bertoletti A., Sette A., Chisari F.V., Penna A., Levrero M., De Carli M., et al. Natural variants of cytotoxic epitopes are T cell receptor antagonists for anti-viral cytotoxic T cells. Nature 369 (1994) 407-410
23. Lok A.S., Heathcote J., and Hoofnagle J.H. Management of hepatitis B. Summary recommendations. Gastroenterology 120 (2001) 1828-1853
24. Soderholm J., Ahlen G., Kaul A., Frelin L., Alheim M., Barnfield C., et al. Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut 55 (2006) 266-274
25. Henke-Gendo C., Amini-Bavil-Olyaee S., Challapalli D., et al. Symptomatic hepatitis B virus (HBV) reactivation despite reduced viral fitness is associated with HBV test and immune escape mutations in an HIV-coinfected Patient. J Infect Dis 198 (2008) 1620-1624